| |
| |
|
| Insider
Information: |
Horobin Joanna |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
44,017 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$21,081 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
44,017 |
|
|
| Total
Value |
$21,081 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Verastem, Inc. |
VSTM |
Chief Medical Officer |
2014-12-29 |
750 |
2014-12-29 |
0 |
Premium* |
|
|
Aceragen, Inc |
ACGN |
Chief Medical Officer |
2019-01-03 |
20,144 |
2018-12-20 |
0 |
Premium* |
|
|
Vyant Bio Ord Shs |
VYNT |
Director |
2023-01-17 |
23,123 |
2022-01-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VYNT |
Vyant Bio Ord Shs |
Director |
– • – |
2023-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
7,526 |
23,123 |
0 |
- |
|
| VYNT |
Vyant Bio Ord Shs |
Director |
– • – |
2022-10-17 |
4 |
A |
$0.00 |
$0 |
D/D |
14,285 |
77,994 |
0 |
- |
|
| VYNT |
Vyant Bio Ord Shs |
Director |
– • – |
2022-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
8,092 |
63,709 |
0 |
- |
|
| VYNT |
Vyant Bio Ord Shs |
Director |
– • – |
2022-04-18 |
4 |
A |
$0.00 |
$0 |
D/D |
6,796 |
55,617 |
0 |
- |
|
| VYNT |
Vyant Bio Ord Shs |
Director |
– • – |
2022-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
43,478 |
48,821 |
0 |
- |
|
| VYNT |
Vyant Bio Ord Shs |
Director |
– • – |
2022-01-18 |
4 |
A |
$1.31 |
$6,999 |
D/D |
5,343 |
5,343 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Chief Medical Officer |
• – – |
2019-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
18,100 |
20,144 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Chief Medical Officer |
• – – |
2018-12-20 |
4 |
B |
$3.45 |
$1,035 |
D/D |
300 |
2,044 |
2.66 |
- |
|
| VSTM |
Verastem, Inc. |
Chief Medical Officer |
• – – |
2014-12-29 |
4 |
B |
$8.60 |
$6,450 |
D/D |
750 |
750 |
2.74 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
